List of LegoChem Biosciences patents

Patents where

Current Assignee

Name

LegoChem Biosciences

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11173214 Antibody-drug conjugates comprising branched linkers and methods related thereto	Patent 11173214 was granted and assigned to LegoChem Biosciences on November, 2021 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	11173214	November 16, 2021
‌ US Patent 10980890 Compounds comprising self-immolative group	Patent 10980890 was granted and assigned to LegoChem Biosciences on April, 2021 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	10980890	April 20, 2021
‌ US Patent 11167040 Conjugates comprising peptide groups and methods related thereto	Patent 11167040 was granted and assigned to LegoChem Biosciences on November, 2021 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	11167040	November 9, 2021
‌ US Patent 10383949 Compounds comprising self-immolative group	Patent 10383949 was granted and assigned to LegoChem Biosciences on August, 2019 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	10383949	August 20, 2019
‌ US Patent 10118965 Compositions and methods related to anti-EGFR antibody drug conjugates	Patent 10118965 was granted and assigned to LegoChem Biosciences on November, 2018 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	10118965	November 6, 2018
‌ US Patent 9993568 Compounds comprising self-immolative group	Patent 9993568 was granted and assigned to LegoChem Biosciences on June, 2018 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	9993568	June 12, 2018
‌ US Patent 9669107 Antibody-active agent conjugates and methods of use	Patent 9669107 was granted and assigned to LegoChem Biosciences on June, 2017 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	9669107	June 6, 2017
‌ US Patent 10183997 Compositions and methods related to anti-CD19 antibody drug conjugates	Patent 10183997 was granted and assigned to LegoChem Biosciences on January, 2019 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	10183997	January 22, 2019
‌ US Patent 9919057 Compounds comprising self-immolative group	Patent 9919057 was granted and assigned to LegoChem Biosciences on March, 2018 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	9919057	March 20, 2018
‌ US Patent 10961242 Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same	Patent 10961242 was granted and assigned to LegoChem Biosciences on March, 2021 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	10961242	March 30, 2021
‌ US Patent 9630977 Cephalosporin derivatives and pharmaceutical compositions thereof	Patent 9630977 was granted and assigned to LegoChem Biosciences on April, 2017 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	9630977	April 25, 2017
‌ US Patent 10273235 Compositions and methods for inhibiting β-lactamase	Patent 10273235 was granted and assigned to LegoChem Biosciences on April, 2019 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	10273235	April 30, 2019
‌ US Patent 11548883 Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same	Patent 11548883 was granted and assigned to LegoChem Biosciences on January, 2023 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	11548883	January 10, 2023
‌ US Patent 8703939 Method for preparing (R)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1H)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives	Patent 8703939 was granted and assigned to LegoChem Biosciences on April, 2014 by the United States Patent and Trademark Office.		LegoChem Biosciences	United States Patent and Trademark Office	8703939	April 22, 2014
‌ US Patent 8846669 Oxazolidinone derivative and medical composition containing same	Patent 8846669 was granted and assigned to LegoChem Biosciences on September, 2014 by the United States Patent and Trademark Office.		LegoChem Biosciences	United States Patent and Trademark Office	8846669	September 30, 2014
‌ US Patent 9951072 Compositions and methods for inhibiting beta-lactamase	Patent 9951072 was granted and assigned to LegoChem Biosciences on April, 2018 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	9951072	April 24, 2018
‌ US Patent 10583197 Antibody-active agent conjugates and methods of use	Patent 10583197 was granted and assigned to LegoChem Biosciences on March, 2020 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	10583197	March 10, 2020
‌ US Patent 8242113 Oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone pharmaceutical compositions thereof	Patent 8242113 was granted and assigned to LegoChem Biosciences on August, 2012 by the United States Patent and Trademark Office.		LegoChem Biosciences	United States Patent and Trademark Office	8242113	August 14, 2012
‌ US Patent 8329684 Cephalosporin derivatives and pharmaceutical compositions thereof			LegoChem Biosciences	United States Patent and Trademark Office	8329684	December 11, 2012
‌ US Patent 11975076 Antibody-drug conjugates comprising branched linkers and methods related thereto	Patent 11975076 was granted and assigned to LegoChem Biosciences on May, 2024 by the United States Patent and Trademark Office.	LegoChem Biosciences	LegoChem Biosciences	United States Patent and Trademark Office	11975076	May 7, 2024

20 results

0 selected

20 results

0 selected